Hexamidine
CAS 3811-75-4
Hexamidine (CAS 3811-75-4) is a Phase 2 pharmaceutical compound with 5 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 31000 nM | 4 | - |
| - | Ki | 5182.666666666667 nM | 3 | - |
| Urokinase-type plasminogen activator Enzyme |
Ki | 4.84 | - | Homo sapiens |
| Prothrombin Enzyme |
Ki | 6.65 | - | Homo sapiens |
| Trypsin-1 Enzyme |
Ki | 5.57 | - | Homo sapiens |
| Suppressor of tumorigenicity 14 protein Enzyme |
Ki | 6.03 | - | Homo sapiens |
| Protein arginine N-methyltransferase 1 Enzyme |
IC50 | 4.28 | - | Homo sapiens |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Hexamidine used for in pharmaceutical contexts?
Hexamidine (CAS 3811-75-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Hexamidine?
No adverse-event association or SIDER side-effect rows are rendered for Hexamidine in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Hexamidine also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Hexamidine with EU status "restricted".
What clinical phase is Hexamidine in?
Hexamidine is rendered with ChEMBL max phase 2.
What bioactivity targets are documented for Hexamidine?
Hexamidine has 7 bioactivity rows in this page query. Rendered target entries include Urokinase-type plasminogen activator, Prothrombin, Trypsin-1, Suppressor of tumorigenicity 14 protein, Protein arginine N-methyltransferase 1.